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Background

Methods

An ongoing focus of pharmaceutical research is enhancing the efficacy of inhaled
drugs indicated to treat lower respiratory infections. To achieve this, an inhaled drug
must exhibit a high aerosolisation performance, or the ability of fine particles to
disperse and reach the target site in the lower respiratory passageways. Proper
deposition of the aerosol particles at the site of action is dependent upon chemical
properties and the aerodynamic diameter. Preliminary data demonstrated that the
aerosolisation performance of colistin, a hydroscopic antibiotic, notably decreased
when stored at a relative humidity (RH) of 75% due to moisture absorption. To
prevent moisture absorption, my aim is to combine two antibiotics, colistin and
azithromycin, into one formulation to improve the combination drug’s delivery to the
target site of action and produce a synergistic effect. The use of azithromycin, an
antibiotic that exhibits hydrophobic properties, would minimize water absorption and
increase the drug’s efficacy. A better understanding of colistin and azithromycin’s
aerosolisation properties is important in strengthening therapeutic methods to treat
individuals with specific pulmonary disorders.

1) Spray Drying (Colistin:Azithromycin, 1:1)

Figure 1 (left): Particles with aerodynamic sizes 1-5 um will
mostly deposit in the lower airways, while particles with
aerodynamic sizes > 5 um will normally deposit in the upper
airways due to inertial impaction.[1]
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Results

Figure 6 (left): The two graphs display the
values for emitted dose (% of drug emitted
from capsule and device that is deposited in the
throat and 8 stages) and the values for FPF,
which surpassed the target goal of 50%. The
optimal formulation was selected based on the
FPF value and percent yield.

Spray drying is a dehydration process in which a liquid is converted to a powder
form. Compressed air atomizes the solution into fine droplets, followed by a rapid
drying process by hot gas, resulting in a fine powder.[6]

Figure 3: A 3-fluid nozzle spray drying system consists of three separate channels, one each for
the 1) core, 2) shell liquid, and 3) atomising gas. The shell and core liquids arrive at the tip of the
nozzle to form a concentric liquid, which is atomized and dried by hot gas to produce the coreshell microcapsules.[6]

2) Next Generation Impactor (NGI)

Figure 4: Larger particles with a greater
aerodynamic diameter will deposit in the
earlier stages while the smallest particles will
deposit in the latter stages, specially in
MOC, a collection cup that captures
extremely small particles.[3]

Figure 2 (above): Distribution of radiolabeled powder
aerosols of mannitol in the lungs using single photon
emission tomography (SPECT).[1]

An important factor influencing lung deposition and the efficacy of inhaled drugs is
particle size, or aerodynamic diameter (um). In regards to particle size, the FPF value,
or fine particle fraction, is the value of interest, and it is the fraction of the total drug
dose < 5.0 um.[2] Our research goal is to obtain an FPF value of > 50%.

Hypothesis
We hypothesize that encapsulating colistin with azithromycin will improve drug
stability by preventing moisture absorption, and therefore, enhance dispersion to the
target site and overall aerosolisation performance.

Research Goal
1) Optimize spray-drying process for 3-fluid nozzle by manipulating three
independent variables: flow rate, inlet temperature, and feed concentration
2) Understand the mixing behavior with 3-fluid nozzle

The NGI measures in-vitro aerosol performance and is used to classify aerosol particles
into size fractions for testing dry powder inhalers. Essentially, this device mimics the
human respiratory system and consists of 8 stages, with the early stages representing the
upper airways (stage 1: human throat) and the latter stages mimicking the lower airways
(stage 8: alveoli of lungs). Air passes through the impactor, and particle sizing is achieved
by forcing the air stream through a series of nozzles containing progressively reducing jet
diameters. The fine particles from each stage are collected in a series of collection cups.[5]

3) High-performance liquid chromatography (HPLC)
HPLC is performed to separate, identify, and quantify the mixture of azithromycin
and colistin. A pump forces the mixture through a column under high pressure.
Azithromycin and colistin are separated from one another due to different
interactions with the stationary phase or column material. Each component
possesses a distinct retention time, or the time it takes for a solute to pass through
the column. The computer output displays a series of peaks, each one representing a
component in the mixture passing through the detector and absorbing UV light.[4]

Figure 7 (above) : Eleven different
formulations were performed with
varying flow rates, inlet
temperatures, and feed
concentrations.
Figure 8 (left): The graphs show
there was no significant difference
in the FPF values when optimal
formulation #3 was exposed to
20% RH for 24 hours and 75% RH
for 24 hours.
Figure 9 (right):
Results produced from
SEM (scanning electron
microscopy) depict small
particles adhesive to
larger particles. The small
particles represent
azithromycin
surrounding the colistin
core, the larger particle.
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Discussion
The graphs suggest azithromycin in combination with colistin successfully
prevented moisture absorption due to no significant changes in FPF values as RH
increased. In other words, the combination of azithromycin and colistin improved
drug stability at greater humidity levels and overall aerosolisation performance.
Furthermore, the data suggest that rather than coating colistin, azithromycin acts to
minimize the interfacial tension between colistin and water particles, ultimately
preventing aggregation.
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